Currently there is no effective treatment for most GBM patients. The development of GBM_INT001 may provide a new small-molecule drug for treating GBM. The successful completion of this project could lead to the promotion of local pharmacological industry, academic research and medical care system.
|Effective start/end date||8/1/21 → 7/31/22|
- Glioblastoma multiforme
- Glioma stem cells
- new drug development
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.